10-Q: Clearwater Paper Reports Q3 Loss Amid Impairment

Clearwater Paper Corporation reported a significant net loss in Q3 2025, primarily driven by a $48 million goodwill impairment charge, despite a slight increase in net sales.

Summary

• Reported a net loss of $53.3 million for the third quarter ended September 30, 2025, compared to a net income of $5.8 million in the prior year period.
• Net sales for the third quarter increased by 1% to $399.0 million, while nine-month net sales increased by 17% to $1,169.0 million, largely due to the Augusta operations acquisition.
• Incurred a non-cash goodwill impairment charge of $48.0 million in the third quarter of 2025, representing a full impairment of goodwill, attributed to paperboard market softness and increased capacity.
• Adjusted EBITDA from continuing operations decreased by 15% to $17.8 million for the third quarter but increased by 229% to $87.4 million for the nine months ended September 30, 2025.
• Gross margin for the third quarter decreased by 38% to $18.8 million, with gross margin percentage falling from 8% to 5%.
• Selling, general and administrative expenses decreased by 22% in the third quarter and 11% for the nine months, reflecting cost reduction efforts.
• Net cash flows provided by operating activities for the nine months ended September 30, 2025, were $7.3 million, a significant decrease from $96.5 million in the prior year, partly due to a $57 million income tax payment related to the tissue divestiture.
• The company finalized the working capital adjustment for its tissue operations divestiture, resulting in a $1.1 million gain in Q3 2025 and a final cash payment of $12.1 million.
• Capital expenditures for 2025 are projected to be approximately $85 million to $90 million.
• A stock repurchase program authorized up to $100 million, with $79.5 million remaining as of July 31, 2025; $17.2 million was used for repurchases in the first nine months of 2025.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a substantial net loss driven by a significant goodwill impairment, decreased gross margin and Adjusted EBITDA in the quarter, and a sharp decline in operating cash flow. While nine-month sales and Adjusted EBITDA show growth, the underlying market softness and the impairment charge indicate significant headwinds and valuation concerns. The ongoing PFAS litigation adds further uncertainty.

Positives

• Net sales increased by 1% for the quarter and 17% for the nine months ended September 30, 2025, driven by higher sales volume, particularly from the Augusta operations.
• Selling, general and administrative expenses decreased by 22% for the quarter and 11% for the nine months, indicating successful cost reduction efforts.
• Adjusted EBITDA from continuing operations for the nine months ended September 30, 2025, significantly increased by 229% to $87.4 million.
• The cost reduction plan is yielding benefits, with $5.0 million in severance expense recorded for the nine months, part of an expected $5-7 million total.
• Finalized the working capital adjustment for the tissue business divestiture, resulting in a $1.1 million gain in the third quarter of 2025.
• The One Big Beautiful Bill Act (OBBBA) was signed into law, making 100% bonus depreciation and other tax benefits permanent, though no material impact was seen in Q3 2025.

Negatives

• Reported a net loss of $53.3 million for the third quarter of 2025, a substantial decline from a net income of $5.8 million in the prior year.
• Incurred a $48.0 million non-cash goodwill impairment charge in Q3 2025, fully impairing goodwill, due to paperboard market softness and increased capacity.
• Gross margin decreased by 38% for the quarter, from $30.1 million to $18.8 million, and the gross margin percentage fell from 8% to 5%.
• Adjusted EBITDA from continuing operations decreased by 15% for the third quarter to $17.8 million.
• Net cash flows provided by operating activities decreased significantly to $7.3 million for the nine months ended September 30, 2025, from $96.5 million in the prior year.
• Long-term debt, net, increased to $335.5 million as of September 30, 2025, from $281.6 million at December 31, 2024.
• Cash and cash equivalents decreased to $34.4 million as of September 30, 2025, from $79.6 million at December 31, 2024.

Risks

• Inability to realize expected benefits, synergies, efficiencies, and financial benefits from the Augusta, Georgia paperboard manufacturing facility acquisition.
• Purchase price adjustments and/or unexpected costs, charges, or expenses resulting from the sale of the consumer products division (tissue business).
• Inability to successfully implement restructuring initiatives in response to the sale of the tissue business.
• Competitive pricing pressures for products due to capacity additions, demand reduction, and foreign currency fluctuations.
• Loss of, change in price for, or reduction in orders from a significant customer.
• Changes in customer or consumer preferences for paperboard grades or substrates.
• Consolidation and vertical integration of converting operations in the paperboard industry.
• Cyclical industry conditions and continued changes in the United States and international economies.
• Increased regulation or retaliatory trade actions in response to announced or proposed U.S. tariffs.
• Manufacturing or operating disruptions, including equipment malfunctions and damage to facilities.
• Changes in the cost and availability of wood fiber, wood pulp, energy, chemicals, packaging, and freight costs.
• Labor disruptions and reliance on a limited number of third-party suppliers.
• Cyber-security risks and IT system disruptions.
• Environmental liabilities or expenditures and climate change, including risks and costs associated with new or ongoing environmental litigation like PFAS-related claims affecting the Augusta facility.
• Inability to execute growth, expansion, and strategic initiatives or successfully execute capital projects.
• Changes in expenses, required contributions, and potential withdrawal costs associated with pension plans.
• Ability to attract, motivate, train, and retain qualified and key personnel.
• Ability to service debt obligations and restrictions from debt covenants and terms.
• Negative changes in credit agency ratings and changes in laws, regulations, or industry standards affecting the business.

Future Outlook

For the fourth quarter of fiscal 2025, sales volumes are expected to decrease due to seasonality. The company anticipates continued benefits from fixed cost reduction efforts but expects energy costs to increase seasonally. Planned major maintenance outage expense at the Augusta, Georgia facility is expected to be lower than the Lewiston, Idaho outage in Q3. The company is negotiating a new union agreement for its Lewiston, Idaho facility, with retroactive wage adjustments expected upon ratification. The impact of new U.S. tariffs is not expected to be significant for fiscal 2025, and the One Big Beautiful Bill Act (OBBBA) had no material impact on Q3 2025 financials.

Management Comments

• "We believe that our cash flows from operations, our cash on hand and our borrowing capacity under our credit agreements will be adequate to fund debt service requirements and provide cash to support our ongoing operations, capital expenditures and working capital needs for the next twelve months."
• "Our relationship with this union remains good and we are negotiating a new agreement. When a new agreement is ratified, we expect to incur retroactive payments on wage increases back to the expiration date."
• "Although we believe that our claims [related to Augusta R&W insurance] are meritorious, no assurance can be given as to whether we will recover all, or any part, of the losses for which we have made such claims."

Industry Context

The company operates in a competitive and cyclical paperboard market. The filing highlights 'paperboard market softness' and 'additional market capacity coming online' as key drivers for the goodwill impairment. These factors suggest an oversupply or reduced demand environment, leading to competitive pricing pressures and impacting profitability across the industry. The company's strategic focus on servicing independent converters in North America positions it within a specific niche, but it remains susceptible to broader market dynamics.

Management Changes

Legal Proceedings

• The company was named as a defendant in an environmental lawsuit filed on February 5, 2025, in Georgia, related to alleged perand poly-fluoroalkyl substances (PFAS) in the plaintiff's source water supply, stemming from the Augusta, Georgia facility. The company intends to vigorously defend this matter.

Stakeholder Impact

• **Shareholders:** Negative impact due to significant net loss, goodwill impairment, and decreased stock price (implied by impairment trigger). Potential for further dilution if capital raise occurs. Stock repurchase program offers some support.
• **Employees:** Impacted by the cost reduction plan, including severance costs. Union negotiations at Lewiston, Idaho facility are ongoing, with potential for retroactive wage adjustments.
• **Customers:** Increased sales volumes suggest continued demand, but market-driven price decreases indicate competitive pressures.
• **Creditors:** Increased long-term debt and reduced cash flow from operations could raise concerns, though the company states it expects to remain in compliance with debt covenants.
• **Local Communities (Augusta, GA):** Affected by the environmental lawsuit related to PFAS, which could have reputational and financial implications for the company and the community.

Next Steps

• Complete the planned major maintenance outage at the Augusta, Georgia facility in the fourth quarter of 2025.
• Continue negotiating a new union agreement for the Lewiston, Idaho facility, with retroactive wage adjustments expected upon ratification.
• Vigorously defend against the environmental lawsuit related to PFAS at the Augusta facility.
• Pursue the representation and warranty insurance claim related to the Augusta acquisition, seeking recovery for alleged breaches.

Key Dates

Recommendation

The company reported a substantial net loss for the quarter, primarily due to a significant goodwill impairment charge, which reflects underlying issues like paperboard market softness and increased capacity. While nine-month sales and Adjusted EBITDA show growth, the quarterly performance deterioration, coupled with declining operating cash flow and increased debt, signals significant operational and financial headwinds. The ongoing PFAS litigation and uncertainty around the Augusta acquisition insurance claim add further risk. These factors suggest a challenging outlook and potential for continued pressure on profitability and valuation, warranting a 'sell' recommendation for investors.

Keywords

Paperboard, Packaging, SEC Filing, 10-Q, Financial Results, Goodwill Impairment, Augusta Acquisition, Tissue Divestiture, Cost Reduction, PFAS Litigation, Capital Expenditures, Stock Repurchase, Manufacturing, Pulp, Forest Products